An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate

Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine Introduction

(2016) Angela K. Shen et al.   HEALTH AFFAIRS

The Evolution of the Meningitis Vaccine Project

(2015) Kathleen Tiffay et al.   CLINICAL INFECTIOUS DISEASES

The Capsule Polymerase CslB ofNeisseria meningitidisSerogroup L Catalyzes the Synthesis of a Complex Trimeric Repeating Unit Comprising Glycosidic and Phosphodiester Linkages

(2015) Christa Litschko et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Vaccine shortage threatens spread of meningitis in Niger

(2015) John Maurice   LANCET

Make vaccine coverage a key UN health indicator

(2015) Seth Berkley   NATURE

Cellular and molecular biology ofNeisseria meningitidiscolonization and invasive disease

(2015) Darryl J. Hill et al.   CLINICAL SCIENCE

Process development and immunogenicity studies on a serogroup ‘X’ Meningococcal polysaccharide conjugate vaccine

(2014) Srinivas Reddy Chilukuri et al.   BIOLOGICALS

Dissection of Hexosyl- and Sialyltransferase Domains in the Bifunctional Capsule Polymerases fromNeisseria meningitidisW and Y Defines a New Sialyltransferase Family

(2014) Angela Romanow et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Molecular Cloning and Functional Characterization of Components of the Capsule Biosynthesis Complex ofNeisseria meningitidisSerogroup A

(2014) Timm Fiebig et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Engineering the product profile of a polysialyltransferase

(2014) Timothy G Keys et al.   Nature Chemical Biology

Vaccines against poverty

(2014) C. A. MacLennan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Meningococcal X polysaccharide quantification by high-performance anion-exchange chromatography using synthetic N-acetylglucosamine-4-phosphate as standard

(2013) F. Micoli et al.   ANALYTICAL BIOCHEMISTRY

Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: A new perspective for vaccine development

(2013) T. Fiebig et al.   GLYCOBIOLOGY

Biochemical and Biophysical Characterization of the Sialyl-/Hexosyltransferase Synthesizing the Meningococcal Serogroup W135 Heteropolysaccharide Capsule

(2013) Angela Romanow et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Neisseria meningitidis serogroup B vaccine development

(2013) Nicole M. Caesar et al.   MICROBIAL PATHOGENESIS

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X

(2013) F. Micoli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bacterial Meningitis Finds New Niche in Gay Communities

(2013) K. Kupferschmidt   SCIENCE

Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine

(2013) Ouli Xie et al.   VACCINE

A high-throughput screen for polysialyltransferase activity

(2012) Timothy G. Keys et al.   ANALYTICAL BIOCHEMISTRY

Prospects for eradication of meningococcal disease

(2012) Simon Nadel   ARCHIVES OF DISEASE IN CHILDHOOD

Glycoconjugate vaccines

(2012) David Pace   EXPERT OPINION ON BIOLOGICAL THERAPY

Relative stability of meningococcal serogroup A and X polysaccharides

(2012) F. Berti et al.   VACCINE

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies

(2012) Ouli Xie et al.   VACCINE

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications

(2011) Michael Bröker et al.   BIOLOGICALS

The design of semi-synthetic and synthetic glycoconjugate vaccines

(2011) Paolo Costantino et al.   Expert Opinion on Drug Discovery

Fatal Neisseria meningitidis serogroup X sepsis in immunocompromised patients in Spain. Virulence of clinical isolates

(2011) Diego Vicente et al.   JOURNAL OF INFECTION

Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso

(2011) Isabelle Delrieu et al.   PLoS One

Neisseria meningitidis Serogroup X Sequence Type 767 in Turkey

(2010) A. Kilic et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Advances in the Development of Vaccines againstNeisseria meningitidis

(2010) Lionel K.K. Tan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development

(2009) Helena Lo et al.   LANCET INFECTIOUS DISEASES

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis

(2009) David S. Stephens   VACCINE